1995
DOI: 10.1055/s-0038-1649796
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Immunological and Functional Assays for Measurement of Soluble Fibrin

Abstract: SummaryVarious assays have been developed for quantitation of soluble fibrin or fibrin monomer in clinical plasma samples, since this parameter directly reflects in vivo thrombin action on fibrinogen. Using plasma samples from healthy blood donors, patients with cerebral ischemic insult, patients with septicemia, and patients with venous thrombosis, we compared two immunologic tests using monoclonal antibodies against fibrin-specific neo-epitopes, and two functional tests based on the cofactor activity of solu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
0

Year Published

1999
1999
2018
2018

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(22 citation statements)
references
References 25 publications
1
21
0
Order By: Relevance
“…Although this confirms our previous results with twice the dose of LPS, our findings are at variance with clinical trials 10,22 that reported increases in soluble fibrin with similar assays. Differences in sensitivity between chromogenic assays and EIA for soluble fibrin have been described previously, particularly at soluble fibrin levels Ͻ10 g/mL, 33,34 and are a likely explanation for the discrepancies between the functional assay and the TpP assay found in our trial (Figure 2).…”
Section: Discussionsupporting
confidence: 59%
“…Although this confirms our previous results with twice the dose of LPS, our findings are at variance with clinical trials 10,22 that reported increases in soluble fibrin with similar assays. Differences in sensitivity between chromogenic assays and EIA for soluble fibrin have been described previously, particularly at soluble fibrin levels Ͻ10 g/mL, 33,34 and are a likely explanation for the discrepancies between the functional assay and the TpP assay found in our trial (Figure 2).…”
Section: Discussionsupporting
confidence: 59%
“…This results in the formation of fibrin monomer, which will be cross‐linked to fibrin under the influence of Factor XIIIa (Dempfle et al, 1995; Dempfle, 1999). Fibrin monomer is a precise and sensitive indicator of an activated state of coagulation and is well suited for early diagnosis of venous thrombosis and DIC in humans (Dempfle et al, 1995; Vogel et al, 1996; Wada et al, 1996; Dempfle, 1999). In the horse fibrin monomer is also a very sensitive marker of an activated coagulation state, which increases before DIC (Feige et al, 1999) or jugular vein thrombosis (Stern‐Balestra, 2000) become apparent.…”
Section: Discussionmentioning
confidence: 99%
“…DIC is an acquired disorder that induces the exhaustion of platelets, coagulation and fibrinolytic factors and causes multiple microvascular thrombi which contribute to the development of multiple organ failure. Proinflammatory cytokines trigger the development of DIC via the tissue factor‐dependent pathway of coagulation (7).…”
Section: Introductionmentioning
confidence: 99%